Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab

BACKGROUND: We investigated the association of peripheral blood inflammatory markers with overall survival (OS) in pembrolizumab treated advanced non-small cell lung cancer (aNSCLC) patients with programmed death ligand 1 (PD-L1) expression ≥50%. Clinical risk factors for development of immune-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ksienski, Doran, Wai, Elaine S., Alex, Deepu, Croteau, Nicole S., Freeman, Ashley T., Chan, Angela, Patterson, Tiffany, Clarkson, Melissa, Fiorino, Leathia, Poonja, Zia, Fenton, David, Irons, Sarah, Lesperance, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867765/
https://www.ncbi.nlm.nih.gov/pubmed/33569318
http://dx.doi.org/10.21037/tlcr-20-541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867765/
https://www.ncbi.nlm.nih.gov/pubmed/33569318
http://dx.doi.org/10.21037/tlcr-20-541

Ejemplares similares